The inhibitory effect of aluminium on the (Na+/K+)ATPase activity of rat brain cortex synaptosomes.
The effect of AlCl(3) on the (Na(+)/K(+))ATPase activity of freeze-thawed synaptosomes, isolated from rat brain cortex, has been studied. The AlCl(3) action on the enzyme hydrolytic activity was examined using in vitro and in vivo approaches. Following exposure to AlCl(3) using both in vitro (synaptosomes incubated in the presence of AlCl(3) for 5 min) and in vivo (synaptosomes isolated from rats that received 0.03 g AlCl(3)/day for 4 months) approaches, the (Na(+)/K(+))ATPase activity was inhibited in a concentration-dependent way. The maximal inhibitory effect (approximately 60%) was observed in the presence of a AlCl(3) concentration >75 microM and at non-limiting ATP concentrations. Conversely, AlCl(3) did not inhibit the enzyme activity when UTP was used as substrate instead of ATP. Analysis of the substrate dependence of membrane-bound (Na(+)/K(+))ATPase by a computer simulation model suggests that the AlCl(3)-induced inhibitory effect is characterised by a reduction of the rate-limiting step velocity of the reaction cycle. Moreover, it seems that aluminium can induce impairment of the interprotomeric interaction within the oligomeric ensemble of membrane-bound (Na(+)/K(+))ATPase. In fact, this effect was accompanied by a slight, but significant, decrease of readily accessible SH groups, which are involved in the maintenance of the membrane-bound (Na(+)/K(+))ATPase oligomeric structure. In conclusion, during exposure to aluminium, reduction of the activation of membrane-bound (Na(+)/K(+))ATPase by high ATP concentrations occurs, which results in a partial inhibition of the enzyme.
D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000378:metabolism; D000535:Aluminum / Q000737:chemistry / Q000494:pharmacology*; D000818:Animals; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D003198:Computer Simulation; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D007700:Kinetics; D008274:Magnesium / Q000737:chemistry / Q000494:pharmacology; D008297:Male; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*; D013379:Substrate Specificity; D013438:Sulfhydryl Compounds / Q000032:analysis; D013574:Synaptosomes / Q000737:chemistry / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D014544:Uridine Triphosphate / Q000378:metabolism
D004791:Enzyme Inhibitors; D013438:Sulfhydryl Compounds; D010042:Ouabain; D000255:Adenosine Triphosphate; D000535:Aluminum; D000254:Sodium-Potassium-Exchanging ATPase; D008274:Magnesium; D014544:Uridine Triphosphate